Ultrasound‐Triggered Nanoparticles Induce Cuproptosis for Enhancing Immunogenic Sonodynamic Therapy
Source abstract
Abstract
Abstract Cuproptosis, as a novel mechanism of cell death, holds significant promise for tumor therapy. However, existing studies typically employ methods to induce cuproptosis through endogenous or exogenous pathways, which often fail to achieve precise control in both space and time. Herein, polymeric nanoparticles (RC NPs) are developed that enable precise activation of cuproptosis through acoustic control for tumor‐specific treatment. The nanoparticles are fabricated via self‐assembly of a degradable, acoustic‐sensitive polymer (Poly RA) and a metal‐ion‐loadable polyphenol‐structured polymer (Poly MPN). Ultrasound stimulation cleaved the RC NPs, generating reactive oxygen species (ROS) and promoting the release of copper ions from Poly MPN, leading to the aggregation of lipoylated proteins and depletion of iron‐sulfur cluster proteins to introduce cuproptosis. Subsequently, the RC NPs successfully activated the immune system of mice, promoting the maturation of antigen‐presenting cells and the activation of T lymphocytes. The nanoparticles exhibited good biosafety and significant tumor inhibition in both orthotopic and patient‐derived xenograft (PDX) models. These novel nanoparticles provide a promising modality for the treatment of highly aggressive cancers and a valuable avenue for future clinical applications.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Extracellular vesicles in disease · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Hepatobiliary Surgery China−Japan Friendship Hospital Beijing 100029 China
Department of Chemistry Capital Normal University Beijing 100048 China
Beijing National Laboratory for Molecular Sciences Laboratory of Polymer Physics and Chemistry Institute of Chemistry Chinese Academy of Sciences Beijing 100190 China
Department of Chemical and Biomolecular Engineering University of California Los Angeles CA 90095 USA
Department of Nuclear Medicine Peking University People's Hospital Beijing 100044 China
References (47)
Show source-provided references
1. 10.1002/adma.20231045610.1002/adma.202310456 ↗
2. 10.1021/jacs.4c0347810.1021/jacs.4c03478 ↗
3. 10.1002/advs.20220291410.1002/advs.202202914 ↗
4. 10.1126/science.abf052910.1126/science.abf0529 ↗
5. 10.1038/s41571-024-00876-010.1038/s41571-024-00876-0 ↗
6. 10.1038/s41392-022-01229-y10.1038/s41392-022-01229-y ↗
7. 10.1186/s13045-024-01545-610.1186/s13045-024-01545-6 ↗
8. 10.1016/j.pmatsci.2023.10114510.1016/j.pmatsci.2023.101145 ↗
9. 10.1002/advs.20240352010.1002/advs.202403520 ↗
10. 10.1021/acs.nanolett.3c0043410.1021/acs.nanolett.3c00434 ↗
11. 10.1002/anie.20240563910.1002/anie.202405639 ↗
12. 10.1002/adfm.20240202210.1002/adfm.202402022 ↗
13. 10.1002/adfm.20220501310.1002/adfm.202205013 ↗
14. 10.1002/advs.20230938810.1002/advs.202309388 ↗
15. 10.1038/s41467-024-54469-710.1038/s41467-024-54469-7 ↗
16. 10.1016/j.actbio.2025.01.01410.1016/j.actbio.2025.01.014 ↗
17. 10.1016/j.cej.2024.15337310.1016/j.cej.2024.153373 ↗
18. 10.1002/anie.20221705510.1002/anie.202217055 ↗
19. 10.1126/sciadv.adg596410.1126/sciadv.adg5964 ↗
20. 10.1002/EXP.2021002310.1002/EXP.20210023 ↗
21. 10.1002/EXP.2023010010.1002/EXP.20230100 ↗
22. 10.1021/acs.nanolett.4c0228710.1021/acs.nanolett.4c02287 ↗
23. 10.1021/acs.inorgchem.1c0157810.1021/acs.inorgchem.1c01578 ↗
24. 10.1021/acs.organomet.7b0049310.1021/acs.organomet.7b00493 ↗
25. 10.1038/s41467-020-16993-010.1038/s41467-020-16993-0 ↗
26. 10.1038/s41467-024-50020-w10.1038/s41467-024-50020-w ↗
27. 10.1002/adma.20231029810.1002/adma.202310298 ↗
28. 10.1002/adfm.20221342510.1002/adfm.202213425 ↗
29. 10.1002/adma.20230768010.1002/adma.202307680 ↗
30. 10.1002/adma.20230343210.1002/adma.202303432 ↗
31. 10.1002/adma.20221226710.1002/adma.202212267 ↗
32. 10.1002/adma.20240497110.1002/adma.202404971 ↗
33. 10.1002/adma.20220473310.1002/adma.202204733 ↗
34. 10.1002/adfm.20230658410.1002/adfm.202306584 ↗
35. 10.1002/adma.20240681510.1002/adma.202406815 ↗
36. Cao Z. · Sci. Transl. Med. · 2023 · 15 · 717
37. 10.1002/adma.20240311610.1002/adma.202403116 ↗
38. 10.1002/adma.20230566810.1002/adma.202305668 ↗
39. 10.1002/adma.20230004810.1002/adma.202300048 ↗
40. 10.1021/acsnano.3c1237510.1021/acsnano.3c12375 ↗
41. 10.1002/anie.20230520010.1002/anie.202305200 ↗
42. 10.1002/adma.20230579810.1002/adma.202305798 ↗
43. 10.1002/anie.20220148610.1002/anie.202201486 ↗
44. 10.1002/anie.20220354610.1002/anie.202203546 ↗
45. 10.1002/adfm.20221459810.1002/adfm.202214598 ↗
46. 10.1126/sciadv.abq822510.1126/sciadv.abq8225 ↗
47. 10.1038/s41565-023-01562-510.1038/s41565-023-01562-5 ↗